Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
Journal: Nature Communications
Published: 2020-01-31
DOI: 10.1038/s41467-020-14471-1
Affiliations: 9
Go to articleJournal: Nature Communications
Published: 2020-01-31
DOI: 10.1038/s41467-020-14471-1
Affiliations: 9
Go to article